Pharma Research Products’ H1 operating product up 10.8%

[DISCLOSURE] Pharma Research Products (214450) reported on Aug. 12 that its operating profit for the first-half of the year rose 10.8 percent to 7.8 billion won (US$7.1 million) on-year.

Sales increased 36.3 percent to 23.9 billion won and net profit 65.9 percent to 8.8 billion won.